HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sitagliptin successfully ameliorates glycemic control in Werner syndrome with diabetes.

AuthorsTakumi Kitamoto, Minoru Takemoto, Masaki Fujimoto, Takahiro Ishikawa, Shunichiro Onishi, Emiko Okabe, Ryoichi Ishibashi, Kazuki Kobayashi, Harukiyo Kawamura, Koutaro Yokote
JournalDiabetes care (Diabetes Care) Vol. 35 Issue 12 Pg. e83 (Dec 2012) ISSN: 1935-5548 [Electronic] United States
PMID23173144 (Publication Type: Case Reports, Letter)
Chemical References
  • Blood Glucose
  • Dipeptidyl-Peptidase IV Inhibitors
  • Pyrazines
  • Triazoles
  • Sitagliptin Phosphate
Topics
  • Blood Glucose (drug effects)
  • Diabetes Mellitus (drug therapy)
  • Dipeptidyl-Peptidase IV Inhibitors (therapeutic use)
  • Female
  • Humans
  • Middle Aged
  • Pyrazines (therapeutic use)
  • Sitagliptin Phosphate
  • Triazoles (therapeutic use)
  • Werner Syndrome (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: